What Ikon Remedies does

Ikon Remedies Pvt. Ltd. is an India-domiciled, privately-held pharmaceutical company founded in 2002 (with operating history referenced to circa 2000) and headquartered in Nagpur with an additional administrative office in Mumbai. The company develops, manufactures (via third-party or contract partners, given absence of disclosed owned manufacturing facilities), markets, and distributes formulations across four business segments: Pharmaceutical (anti-infectives, analgesics, cardiovascular, gastrointestinal, respiratory, neurological), Nutraceutical (vitamins, minerals, hematinics, calcium, hair-care nutraceuticals), Cosmetics / Personal Care under the Pearldew brand (skincare, haircare, baby care, dental, hygiene), and Ayurvedic.

Its technology base is conventional small-molecule and herbal formulation rather than AI-driven or platform technology, covering 1800+ products across 273 therapeutic groups and 60+ dosage forms including tablets, capsules, syrups, suspensions, injections, and topical preparations. Selected products carry formulation differentiation, such as the Pearldew Total Toothpaste's claimed stain-defense technology and Pearldew Hair Oil's Ayurvedic Kshir Pak Vidhi process, but these are brand-level product differentiators rather than enterprise-grade IP or patent moats. The company has received brand-recognition awards including India's Greatest Brands & Leaders 2016-17 (process reviewed by PwC) and the Best Emerging Pharmaceutical Company in Western India award in 2019, but holds no disclosed patents or regulatory exclusivity.

Ikon Remedies monetises through one-time sales of branded formulations to its customers (wholesalers, distributors, retailers, and registered medical practitioners) across all 36 Indian states and Union Territories, via a network of 2000+ distributors. Pricing is not publicly disclosed, contracts are handled through direct enquiry (phone, email, WhatsApp), and demand generation mixes ethical medical promotion with digital channels (website, Facebook, Instagram, LinkedIn, Google Ads, Meta Ads). The company serves leading Indian pharma enterprises as a supply partner but has no public customer concentration disclosure. It remains founder/closely-held with no institutional funding rounds, acquisitions, or international operations, and operates with 51-100 employees as a mid-sized, India-domestic, distribution-led formulation business.

Name

Ikon Remedies

Legal name

Ikon Remedies Pvt. Ltd.

Website

https://ikonremedies.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

51–100 employees

Short description

Ikon Remedies is a privately-held Indian pharmaceutical company that develops and distributes 1800+ branded formulations across pharma, nutraceutical, cosmetics (Pearldew), and Ayurvedic segments, serving 2000+ distributors, retailers, and medical practitioners across 36 Indian states and Union Territories.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411), Drugs and Druggists' Sundries Merchant Wholesalers (42421), Soap, Cleaning Compound, and Toilet Preparation Manufacturing (3256)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Perfumes, Cosmetics & Other Toilet Preparations (2844), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Cold, Flu & Cough Remedies (HLAIADAB)

akta.pro secondary industries

Allergy, Sinus & Respiratory (Non-Asthma) (HLAIADAC), OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief) (CRADAMAC), Digestive Health OTC (Antacids, Laxatives, Anti-diarrheals, Probiotics OTC) (CRADAMAE), Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal) (CRADAMAF), Tongue Cleaners & Breath Fresheners (CRABAFAI)

Keywords

• Pharmaceutical formulations
• Generic medicines
• Ayurvedic formulations
• Nutraceutical supplements
• Dermatological cosmetics

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. Pharmaceutical Products: Sale of pharmaceutical formulations including tablets, capsules, syrups, injections, suspensions, and topical preparations across multiple therapeutic segments
2. Cosmetic and Personal Care Products: Sale of cosmetics and personal care products under the Pearldew brand including soaps, creams, lotions, hand sanitizers, and hair care products
3. Ayurvedic Products: Sale of Ayurvedic formulations and herbal healthcare products including oils, capsules, and topical preparations
4. Nutraceutical Products: Sale of nutritional supplements including multivitamins, multiminerals, and health supplements

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

Ikon Remedies manufactures and supplies pharmaceutical, ayurvedic, cosmetic, and nutraceutical formulations spanning tablets, capsules, syrups, injections, suspensions, and topical preparations. Its portfolio covers 1800+ products across 273 therapeutic groups and 60+ dosage forms, with the Pearldew brand handling cosmetics and personal care. The company serves healthcare providers, wholesalers, retailers, and other pharmaceutical companies across India.

Product overview

Ikon Remedies is a pharmaceutical company in India operating across four distinct business segments: Pharmaceutical (prescription and OTC medicines), Nutraceutical (nutritional supplements), Cosmetics (personal care under Pearldew brand), and Ayurvedic (herbal formulations). The company offers 1800+ products across 18 specialized segments covering therapeutic areas including anti-inflammatory drugs (Aclozest, Orthomol), antipyretics (Pacinova), antibiotics (Ceflet, Montego, Fixican, Truclave, Azidac, Oflowin, Cefmac), cardiovascular treatments (Atrocard), gastrointestinal medications (Pantiac), neurological supplements (Neurozide), nutritional supplements (Maycal, Hemotag, Zincomax), and respiratory/cough treatments (Tricodex, Rhinorest). The cosmetics segment under the Pearldew brand includes 126+ products spanning skin care (creams, moisturizers, sunscreen), hair care (oils, shampoos, conditioners), baby care, dental care (toothpaste), and hygiene products (hand sanitizers, hand washes). The company serves 36 states and UTs in India through 2000+ distributors.

Differentiator

Problem solved

Functional benefit

Brands

• Pearldew: Cosmetics and personal care brand offering skincare, hair care, baby care, and hygiene products including soaps, moisturizers, hair oils, sanitizers, and toothpaste.
• Aclozest
• Orthomol
• Pacinova
• Groviva
• Hemotag
• Maycal
• Zincomax
• Neurozide
• Ceflet
• Montego
• Fixican
• Truclave
• Tricodex
• Rhinorest
• Azidac
• Atrocard
• Cefmac
• Oflowin
• Pantiac

Products and services

• Pharmaceutical Segment Core pharmaceutical manufacturing and supply of prescription and OTC medicines across multiple therapeutic areas including anti-inflammatory, antibiotics, cardiovascular, gastrointestinal, and neurological treatments. Targeted at wholesalers, retailers, healthcare providers, and leading pharmaceutical companies in India.
• Nutraceutical Segment Nutritional supplements and health products segment including multivitamins, multiminerals, iron supplements (Hemotag), calcium supplements (Maycal), hair care nutraceuticals (Groviva), and topical pain reliever formulations (Orthomol). Targeted at wholesalers, retailers, and consumers seeking supplements.
• Cosmetics and Personal Care Segment (Pearldew) Personal care and cosmetics brand Pearldew offering 126 products spanning skin care, hair care, baby care, dental care, and hygiene including soaps, moisturizers, hair oils, sunscreen lotions, toothpaste, hand sanitizers, and baby products. Targeted at end consumers via retail pharmacy and distribution channels.
• Ayurvedic Segment Ayurvedic medicines and herbal formulations based on traditional Indian medicine science including traditional Ayurvedic preparations such as Pearldew Hair Oil using the Kshir Pak Vidhi process. Targeted at consumers and traditional medicine practitioners across India.
• Aclozest (Aceclofenac) Anti-inflammatory analgesic product line featuring Aceclofenac tablets and suspension with 20 products in the line, positioned as a leading choice amongst pain relievers. Includes Aclozest Cold Tablets launched in November 2025. Targeted at physicians, specialists, and wholesalers.
• Pacinova (Paracetamol) Antipyretic and analgesic product line featuring Paracetamol tablets, suspension, and IV formulations with 15 products. Targeted at physicians, paediatricians, and wholesale distribution.
• Tricodex Cough Formula Mucolytic cough and cold product line with 24 products in multiple variants including Tricodex Syrup, A Syrup, AZ Syrup, and LS Syrup. Targeted at physicians and wholesale distribution.
• Rhinorest Anti-Cold Line Time-tested anti-cold formulation available as 25 products including tablets, suspension, forte tablets, and CCF variants. Targeted at physicians, paediatricians, ENT specialists, and wholesalers.
• Ceflet (Cefuroxime) Second-generation cephalosporin antibiotic product line in tablets and injection forms with 11 products, positioned as a high-performance antibacterial. Targeted at physicians and wholesale distribution.
• Montego (Cefpodoxime) Third-generation cephalosporin antibiotic in tablets and dry syrups, positioned as first-line choice for empirical therapy. Targeted at physicians and wholesale distribution.
• Fixican (Cefixime) Cefixime antibiotic product line for polymicrobial infections available in tablets and dry syrups with 14 products. Targeted at physicians and wholesale distribution.
• Truclave (Co-Amoxiclav) Penicillin antibiotic with Co-Amoxiclav formulation, trusted for various infections. Targeted at physicians and wholesale distribution.
• Azidac (Azithromycin) Purely target-oriented macrolide antibiotic product line featuring Azithromycin with 9 products. Targeted at physicians and wholesale distribution.
• Oflowin (Ofloxacin) Fluoroquinolone antibiotic and anti-infective product line available in tablets, drops, infusion, and cream forms for day-to-day infections. Targeted at physicians and wholesale distribution.
• Cefmac (Ceftriaxone) Injectable ceftriaxone antibiotic product line for tough infections, available in multiple strengths (250mg, 500mg, 1gm, 2gm) plus combination formulations. Targeted at hospitals, physicians, and surgical specialities.
• Atrocard (Atorvastatin) Lipid-lowering atorvastatin product line with 18 products in tablets, capsules, and injections across multiple strengths, positioned to normalize lipid levels and protect heart health. Targeted at cardiologists, physicians, and wholesale distribution.
• Pantiac (Pantoprazole) Proton Pump Inhibitor pantoprazole product line for management of acid peptic disorders, available in tablets, capsules, and injection variants. Targeted at gastroenterologists, physicians, and wholesale distribution.
• Maycal (Calcium Supplement) Calcium supplement product line with 22 products in tablets, suspension, and softgel forms. Targeted at gynaecologists, orthopaedic specialists, and consumers seeking calcium supplementation.
• Hemotag (Iron Supplement) Iron supplement hematinic product line in tablets and syrup forms, including the newly launched Hemotag FMC Injection for hematinic applications. Targeted at gynaecologists, physicians, and consumers.
• Zincomax (Multivitamins and Multiminerals) Nutritional supplement of multivitamins and multiminerals available in tablets, powder, and syrup forms. Targeted at physicians, paediatricians, and consumers.
• Neurozide (Methylcobalamin) Nerve-care product line featuring Methylcobalamin tablets and capsules, positioned as a complete neuroprotector for nerve rejuvenation. Targeted at neurologists, diabetologists, and physicians.
• Groviva (Hair Care) Herbal hair care nutraceutical product line with 12 products in capsules, oil, and serum forms. Targeted at dermatologists and consumers seeking hair care solutions.
• Orthomol (Topical Pain Reliever) Topical herbal pain reliever product line with 10 products in capsules, oil, and gel forms to relieve joint stiffness and pain. Targeted at orthopaedic specialists and consumers.
• Pearldew Hair Oil Ayurvedic hair oil made using the traditional Kshir Pak Vidhi process with 22 highly effective herbs, 19 essential oils, and 2 vital ingredients to control hair fall. Targeted at consumers via retail and pharmacy distribution.
• Pearldew Total Toothpaste Balanced toothpaste formulation providing 12-hour germ protection using stain defense technology to prevent new stain formation and help prevent gingivitis, plaque, and cavities. Targeted at consumers via retail and pharmacy distribution.
• Pearldew Sunscreen Lotion Sunscreen lotions with SPF 30, 50, and 75 protection levels protecting skin against harmful UV rays. Targeted at dermatologists and consumers via retail distribution.
• Pearldew Hand Sanitizer Hand sanitizers available in gel and spray forms in multiple scents (Blueberry, Green Apple, Japanese Cherry Blossom, Sea Breeze, Fruit Basket, Refreshing Orange, Lemon & Mint) that kill 99.9% of germs. Targeted at consumers and healthcare facilities.
• Pearldew Baby Care Products Baby care line including baby massage oil, baby lotion, baby powder, baby diaper rash cream, and baby wash formulated with gentle, natural ingredients. Targeted at paediatricians, new parents, and consumers via retail and pharmacy distribution.
• Acnedac Acne Spot Corrector Cream Acne spot corrector cream for treating and preventing acne spots, launched in April 2026. Targeted at dermatologists and consumers via retail distribution.
• Pearldew Moisturizing Soap Moisturizing soap for daily skin care under the Pearldew cosmetics brand, launched in April 2026. Targeted at consumers via retail and pharmacy distribution.
• Pearldew Daily Hydrating Facial Cleanser Daily hydrating facial cleanser under the Pearldew skincare range, launched in November 2025. Targeted at dermatologists, beauty consumers, and retail distribution.
• Corest-D Syrup Respiratory syrup formulation for cold and cough treatment launched alongside Corest Softgels. Targeted at physicians, paediatricians, and wholesale distribution.
• Nimeda Cold Tablets Cold tablets for anti-cold treatment launched as part of Ikon Remedies' November 2025 product rollout. Targeted at physicians and wholesale distribution.
• Lelet M Tablets Therapeutic tablets for specific treatment indications launched in November 2025. Targeted at physicians and wholesale distribution.

Quantifiable outcome

• 1800+ pharmaceutical products
• +6 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Ipca Laboratories: Diversified Indian pharma manufacturer with strong presence in anti-infectives, pain, and cardiovascular — overlapping therapeutic portfolio and dosage form breadth.
• Ajanta Pharma: Indian pharma company with a broad specialty/OTC portfolio across branded generics in similar therapeutic segments (anti-infectives, cardiology, dermatology) — comparable on therapeutic breadth and India-focused marketing approach.
• Torrent Pharmaceuticals: Indian pharma group with broad therapy portfolio across chronic and acute segments and strong domestic distribution — comparable breadth and India-focused model.
• Alkem Laboratories: Indian pharma with broad generic and branded formulation portfolio across anti-infectives, pain, GI and other therapeutic areas — comparable operating model and Indian distribution footprint.
• Mankind Pharma: India's largest domestic pharma and OTC consumer health company — directly comparable to Ikon on the pharma-plus-Pearldew-style consumer health hybrid model, and a benchmark for how Ikon could scale if the OTC/Cosmetics segment grew.
• Glenmark Pharmaceuticals: Indian-headquartered pharma with diversified branded generics and growing OTC/consumer health presence — comparable therapeutic and consumer health breadth.
• Unichem Laboratories: India-based formulations manufacturer with diversified therapy presence across multiple dosage forms — comparable in mid-sized Indian pharma formulations positioning.
• Indoco Remedies: Indian-listed formulations company with a similar diversified portfolio spanning multiple therapeutic categories and an India-centric distribution model — directly comparable in breadth, scale and go-to-market approach to Ikon Remedies.

Broad incumbents

• Dabur India: Large Indian conglomerate with dominant Ayurvedic, herbal and consumer health portfolio (Pearldew and Ikon's Ayurvedic segment competes directly) and Pan-India distribution — represents the scaled incumbent the Pearldew and Ayurvedic segments compete against.
• Emami: Large Indian consumer healthcare and personal care company with established brands across skin care, hair care and OTC — directly comparable to the Pearldew cosmetics/personal care business.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/ikonremedies
• LinkedInlinkedin.com/company/ikon-remdies-pvt-ltd
• Instagraminstagram.com/ikon.remedies_

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ikon Remedies